îæ€çŽ¢
îæ€çŽ¢
î
Urogen Pharma Ltd
URGNîãŠã©ãããªã¹ãã«è¿œå
43.490USD
+1.750+4.19%
çµå€Â 09-16 16:00ïŒETïŒ
2.13Bæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
TradingKeyãã£ãŒã
Intraday
1m
30m
1h
D
W
M
D
æ¬æ¥
+4.19%
5æ¥é
-3.36%
1ã¶æ
-9.81%
6ã¶æ
+132.19%
幎åæ¥
+85.70%
1幎é
+140.68%
äž»èŠããŒã¿
42.070å§å€
43.720é«å€
74.42Kåºæ¥é«
æ倱é¡çŽè¿12ã¶æPER
13.20äºæ³PER
--çŽè¿12ã¶æé
åœ
0.15%売買å転ç
41.740åæ¥çµå€
42.070å®å€
3.21M売買代é
æ倱é¡æ ªäŸ¡åçç
-16.05PBRïŒæ ªäŸ¡çŽè³ç£åçïŒ
0.00%çŽè¿12ã¶æé
åœå©åã
-53.15%ç·è³ç£å©çç
50.81052é±é«å€
0.11åºæ¥é«æ¯ç%
-126.87MçŽå©ç
48.87Mæ ªåŒæ°
-2.73531æ ªåœããå©çïŒEPSïŒ
1.61ããŒã¿å€
--èªå·±è³æ¬å©çç
15.86052é±å®å€
3.08%æ¯ãå¹
91.32%ç²å©çç
2.13Bæ䟡ç·é¡
4.16ãªã¹ã¯ãªã¿ãŒã³
4.12%ãªã¹ã¯ç
Urogen Pharma Ltdã®ã¹ã³ã¢î°î°
-0.01ååå€ã«å¯Ÿããæ¯ç
äºæž¬å€8.75
財åå¥å
šæ§8.60
ãã¯ãã«ã«4.11
ããªã¥ãšãŒã·ã§ã³9.20
æ©é¢æè³å®¶ã®ä¿¡é Œæ10.00
ãªã¹ã¯è©äŸ¡5.92
ã¡ãã£ã¢å ±é
å ±éã¬ãã«
éåžžã«äœã
éåžžã«é«ã
äžç«
ã¢ããªã¹ãè©äŸ¡î
Urogen Pharma Ltd ãã¯ãã«ã«åæ
îãã¯ãã«ã«ææš
売ã
èŠçŽ
äžç«
移åå¹³å
è²·ã
財åææšî
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
財åè«žè¡šî
次åå ±åæ¥
--
å ±åæé
2026Q2
財åè«žè¡š / äºæž¬
-0.28/-0.29
åç / äºæž¬
72.46M/63.53M
Urogen Pharma Ltd ãããã£ãŒã«î
ã»ã¯ã¿ãŒãã€ãªãã¯ãããžãŒ & å»çç 究
äŒæ¥ã³ãŒãURGN
åŸæ¥å¡æ°235
åœIsrael
ä¿æç¶æ³î
| æ ªäž»çµ±èš | æ¯ç |
|---|---|
| RTW Investments L.P. | 9.33% |
| Paradigm BioCapital Advisors LP | 9.18% |
| Morgan Stanley & Co. LLC | 5.12% |
| Jefferies LLC | 4.51% |
| çš®é¡ | æ¯ç |
|---|---|
| Investment Advisor | 25.15% |
| Hedge Fund | 24.30% |
| Investment Advisor/Hedge Fund | 21.45% |
| Research Firm | 14.56% |
é¢é£éèåå
+0.15%
+0.03%
+0.64%
-0.20%
+0.78%
+0.06%
+0.19%
+0.94%
-0.33%
-1.93%
-0.27%
-0.20%
-1.36%
+0.56%
+0.45%
+0.06%
+0.50%
-0.32%
+1.29%
-0.05%人æ°éæ
î
51775.700
+310.000Â (+0.60%)
29120.400
+165.400Â (+0.57%)
7593.400
+42.400Â (+0.56%)
14299.000
+36.000Â (+0.25%)
64083.000
-349.000Â (-0.54%)
6297.500
+39.400Â (+0.63%)
99.116
-0.209Â (-0.21%)
332.410
+1.070Â (+0.32%)
213.900
+1.730Â (+0.82%)
4287.430
+24.110Â (+0.57%)
ãããã質å
Urogen Pharma LtdïŒURGNïŒã®çŸåšã®æ ªäŸ¡ã¯ãããã§ããïŒ
îUrogen Pharma LtdïŒURGNïŒã®çŸåšã®æ ªäŸ¡ã¯43.49ã§ãã
Urogen Pharma Ltdã®ãã£ãã«ãŒã·ã³ãã«ã¯äœã§ããïŒ
îUrogen Pharma Ltdã®ãã£ãã«ãŒã·ã³ãã«ã¯URGNã§ãã
Urogen Pharma Ltdã®52é±é«å€ã¯ãããã§ããïŒ
îUrogen Pharma Ltdã®52é±é«å€ã¯50.81ã§ãã
Urogen Pharma Ltdã®52é±å®å€ã¯ãããã§ããïŒ
îUrogen Pharma Ltdã®52é±å®å€ã¯15.86ã§ãã
Urogen Pharma Ltdã®æ䟡ç·é¡ã¯ãããã§ããïŒ
îUrogen Pharma Ltdã®æ䟡ç·é¡ã¯2.13Bã§ãã
Urogen Pharma Ltd (URGN) ã®çŸåšã®è©äŸ¡ã¯ãè²·ããããããŒã«ãããã売ããã®ã©ãã§ããïŒ
îã¢ããªã¹ãã«ãããšãUrogen Pharma LtdïŒURGNïŒã®ç·åè©äŸ¡ã¯è²·ãã§ãç®æšæ ªäŸ¡ã¯60.00ã§ãã
Urogen Pharma Ltd (URGN) ã®1æ ªåœããå©çïŒEPS TTMïŒã¯ãããã§ããïŒ
îUrogen Pharma LtdïŒURGNïŒã®1æ ªåœããå©çïŒEPS TTMïŒã¯-2.74ã§ãã